Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Am J Cardiol. 2023 Oct 15;205:431-441. doi: 10.1016/j.amjcard.2023.08.043. Epub 2023 Sep 1.
The optimal revascularization strategy in patients with multivessel disease and intermediate SYNTAX score (SS) has not been fully elucidated. This study aimed to investigate the clinical outcomes of optimal intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) stratified by SS.
This was a substudy of the OPTIVUS-Complex PCI study Multivessel Cohort, which aimed to meet the prespecified criteria for optimal stent expansion after IVUS-guided PCI. A total of 1,005 patients were divided into 3 groups according to SS: low, ≤22; intermediate, 23 to 32; and high, ≥33. The primary end points were major adverse cardiac and cerebrovascular events (MACCE) defined as a composite of death, myocardial infarction, stroke, or coronary revascularization.
The cumulative 1-year incidence of the primary end point was significantly higher in patients with high SS than in those with intermediate or low SS (25.0%, 10.9%, and 9.5%, respectively; p = 0.003). This difference was mainly caused by the incidence of coronary revascularization. In the multivariable Cox proportional hazards models, the excess risk of patients with high versus low SS remained significant for the primary end point (hazard ratio 3.19, 95% confidence interval 1.65 to 6.16, p <0.001), whereas the excess risk of patients with intermediate versus low SS was no longer significant (hazard ratio 1.20, 95% confidence interval 0.72 to 2.01, p = 0.46).
After IVUS-guided multivessel PCI, patients with intermediate SS had a similar 1-year risk of MACCE to that of patients with low SS, whereas patients with high SS had a higher 1-year risk of MACCE than those with low SS.
多支血管病变且 SYNTAX 评分(SS)处于中间范围的患者的最佳血运重建策略尚未完全阐明。本研究旨在探讨根据 SS 分层的最佳血管内超声(IVUS)指导的经皮冠状动脉介入治疗(PCI)的临床结果。
这是 OPTIVUS-Complex PCI 研究多血管队列的子研究,旨在满足 IVUS 指导 PCI 后最佳支架扩张的预设标准。共有 1005 名患者根据 SS 分为 3 组:低,≤22;中,23 至 32;高,≥33。主要终点是主要不良心脑血管事件(MACCE),定义为死亡、心肌梗死、卒中和冠状动脉血运重建的复合事件。
高 SS 患者的 1 年累积主要终点发生率明显高于中 SS 或低 SS 患者(分别为 25.0%、10.9%和 9.5%;p=0.003)。这种差异主要是由冠状动脉血运重建引起的。在多变量 Cox 比例风险模型中,高 SS 患者与低 SS 患者相比,主要终点的超额风险仍然显著(风险比 3.19,95%置信区间 1.65 至 6.16,p<0.001),而中 SS 患者与低 SS 患者相比,超额风险不再显著(风险比 1.20,95%置信区间 0.72 至 2.01,p=0.46)。
在 IVUS 指导的多血管 PCI 后,中 SS 患者 1 年 MACCE 的风险与低 SS 患者相似,而高 SS 患者 1 年 MACCE 的风险高于低 SS 患者。